Q3 2025 Earnings Call Transcript November 4, 2025 SNDL Inc. misses on earnings expectations. Reported EPS is $-0.04 EPS, ...

SNDL Inc (SNDL) reports strong cash flow and international sales growth, despite facing inventory and market headwinds in Q3 ...

Welcome to SNDL's Third Quarter 2025 Financial and Operational Results Conference Call. The third quarter of 2025 marks another milestone for SNDL as we report record quarterly free cash flow. And for ...

The Edmonton, Alberta, company's net loss narrowed in the third quarter to 13.3 million Canadian dollars ($9.5 million), or C$0.05 a share, from a year-earlier loss of C$19.3 million, or C$0.07.

SNDL (SNDL) stock falls, and its Canadian cannabis peers also decline after the company posted its Q3 2025 results. Read more ...

The Company Delivers Strong Cash Flow and Record Free Cash FlowEDMONTON, Alberta, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SNDL Inc.

FDA feedback enables CervoMed to proceed with proposed endpoints, patient enrichment strategy, and other key aspects of Phase 3 trial design to support potential New Drug Application ...

Rhythm Pharmaceuticals will host a live conference call and webcast at 8:00 a.m. ET today to review its third quarter 2025 financial results and recent business activities. Participants may register ...

SNDL Inc. has released its financial statements for the three and nine months ended September 30, 2025. The report highlights a net revenue of $244.2 million for the third quarter, showing an increase ...

A turbulent week for Wall Street continued on Wednesday with trade tensions, the government shutdown, and a solid wave of earnings reports all battling for investor attention The S&P 500 rose 0.4%.

Our team of savvy editors independently handpicks all recommendations. If you purchase through our links, the USA Today Network may earn a commission. Prices were accurate at the time of publication ...

EDMONTON, Alberta, Oct. 15, 2025 (GLOBE NEWSWIRE) -- SNDL Inc. (Nasdaq: SNDL, CSE: SNDL) ("SNDL ") announced today that it will release its third quarter 2025 financial results for the period ended ...